Zevra Therapeutics, Inc. (ZVRA) short interest & options flow
NASDAQZevra Therapeutics heads into its November 9 earnings report with a notable gap between what short sellers are betting and what analysts are saying. Short interest is genuinely elevated at 10.4% of the free float, around 5.9 million shares, and has edged up roughly 0.8% over the past week after trending lower through September from a peak near 6.2 million shares in early that…
ZVRA short interest surges 25.7% in one week to 11.0% of float, driven by stock rallying 23% amid analyst upgrade wave.
- Market cap
- $691M
- Next earnings
- 9 Nov 2026
Key data as of 7 Nov 2026

ZVRA news and analysis
RSSNo long-form analysis yet for ZVRA. Pulse alerts and the live data picture are available on ORTEX.
Open ZVRA on ORTEX →Want the live picture for ZVRA?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ZVRA — free to start on ORTEX.
Sign up for free →Open ZVRA on ORTEX